Visceral Adiposity Index
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To individuate a novel sex-specific index, based on waist circumference, BMI, triglycerides, and HDL cholesterol, indirectly expressing visceral fat function. RESEARCH DESIGN AND METHODS: Visceral adiposity index (VAI) was first modeled on 315 nonobese healthy subjects. Using two multiple logistic regression models, VAI was retrospectively validated in 1,498 primary care patients in comparison to classical cardio- and cerebrovascular risk factors. RESULTS: All components of metabolic syndrome increased significantly across VAI quintiles. VAI was independently associated with both cardiovascular (odd ratio [OR] 2.45; 95% CI 1.52–3.95; P < 0.001) and cerebrovascular (1.63; 1.06–2.50; P = 0.025) events. VAI also showed significant inverse correlation with insulin sensitivity during euglycemic-hyperinsulinemic clamp in a subgroup of patients (Rs = −0.721; P < 0.001). By contrast, no correlations were found for waist circumference and BMI. CONCLUSIONS: Our study suggests VAI is a valuable indicator of “visceral adipose function” and insulin sensitivity, and its increase is strongly associated with cardiometabolic risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“increased fat mass is associated with elevated adipocytokine and proinflammatory cytokines, insulin resistance, increased risk of developing adverse outcomes of diabetes, hypertriglyceridemia, hypercholesterolemia, hypertension, atherosclerosis, and a higher mortality rate [10].”
From Trend of various adiposity indices in women with and without history of gestational diabetes: a population-based cohort study (2019) · cites this paper as [10]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pouliot, M.-C., Després, J.-P., Lemieux, S., Moorjani, S., Bouchard, C., Tremblay, A., Nadeau, A., & Lupien, P. J. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90676-9 · Cited by 2,085
Ohlson, L. O., Larsson, B., Svärdsudd, K., Welin, L., Eriksson, H., Wilhelmsen, L., Björntorp, P., & Tibblin, G. (1985) · Diabetes · doi:10.2337/diab.34.10.1055 · Cited by 1,020
Unger, R. H. (2003) · Endocrinology · doi:10.1210/en.2003-0870 · Cited by 677 · cited 1×
“Indeed, this condition characterized by visceral obesity and “high-triglyceride/low–HDL cholesterol dyslipidemia” has been associated with physiological age-linked leptin resistance, muscle, and liver insulin resistance, lipotoxic cardiomyopathy, and generalized endothelial dysfunction (15).”
BackgroundIs visceral obesity the cause of the metabolic syndrome?
Després, J. (2006) · Annals of Medicine · doi:10.1080/07853890500383895 · Cited by 651
Age-related inflammatory cytokines and disease
Brüünsgaard, H., & Pedersen, B. K. (2003) · Immunology and Allergy Clinics of North America · doi:10.1016/s0889-8561(02)00056-5 · Cited by 608 · cited 1×
“V isceral obesity (1) is associated with increased adipocytokine production, proinflammatory activity (2), deterioration of insulin sensitivity (3), increased risk of developing diabetes, “high-triglyceride/low–HDL cholesterol dyslipidemia,” hypertension, atherosclerosis, and higher mortality rate (4–7).”
BackgroundSubdivisions of subcutaneous abdominal adipose tissue and insulin resistance
Kelley, D. E., Thaete, F. L., Troost, F., Huwe, T., & Goodpaster, B. H. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.278.5.e941 · Cited by 538
Body fat distribution, insulin resistance, and metabolic diseases
Björntorp, P. (1997) · Nutrition · doi:10.1016/s0899-9007(97)00191-3 · Cited by 470
High Visceral and Low Abdominal Subcutaneous Fat Stores in the Obese Adolescent
Taksali, S. E., Caprio, S., Dziura, J., Dufour, S., Calí, A. M. G., Goodman, T. R., Papademetris, X., Burgert, T. S., Pierpont, B. M., Savoye, M., et al. (2008) · Diabetes · doi:10.2337/db07-0932 · Cited by 353
Rader, D. J. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.01.003 · Cited by 346
Visceral Fat in Hypertension: Influence on Insulin Resistance and β-Cell Function
Sironi, A. M., Gastaldelli, A., Mari, A., Ciociaro, D., Postano, V., Buzzigoli, E., Ghione, S., Turchi, S., Lombardi, M., & Ferrannini, E. (2004) · Hypertension · doi:10.1161/01.hyp.0000137982.10191.0a · Cited by 268
Research works printed but not linked: 1
- De Fronzo, 1979, The glucose clamp technique: a method for the quantification of beta cell sensitivity to glucose and of tissue sensitivity to insulin, Am J Physiol, 237, 214
Cited by
Items 201–300 of 1,005
Eckard, A. R., Wu, Q., Sattar, A., Ansari-Gilani, K., Labbato, D., Foster, T., Fletcher, A. A., Adekunle, R. O., & McComsey, G. A. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00150-5 · Cited by 55
Kapoor, N., Jiwanmall, S. A., Nandyal, M. B., Kattula, D., Paravathareddy, S., Paul, T. V., Furler, J., Oldenburg, B. F., & Thomas, N. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s266277 · Cited by 55
Lu, S., & Cao, Z. (2023) · Nutrients · doi:10.3390/nu15224832 · Cited by 55
“…index incorporating waist circumference, triglycerides, and HDL to indirectly represent VAT function) and a homeostatic model assessment of insulin resistance (HOMA-IR), ultimately resulting in poorer metabolic parameters when compared to their metabolically healthy obese counterparts [51,52].”
BackgroundChen, Y., Huang, R., Mai, Z., Chen, H., Zhang, J., Le, Z., Yang, Z., Yu, H., Kong, D., & Ding, Y. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1331159 · Cited by 55
Liu, L., Peng, J., Wang, N., Wu, Z., Zhang, Y., Cui, H., Zang, D., Lu, F., Ma, X., & Yang, J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1290226 · Cited by 55
Stȩpień, M., Stępień, A., Wlazeł, R. N., Paradowski, M. T., Banach, M., Rysz-Górzyńska, M., & Rysz, J. (2013) · Medical Science Monitor · doi:10.12659/msm.889390 · Cited by 55
Mazza, A., Fruci, B., Guzzi, P. H., D'Orrico, B., Malaguarnera, R., Veltri, P., Fava, A., & Belfiore, A. (2013) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2013.04.016 · Cited by 55
“The VAI-index, recently described as an indicator of both fat distribution and function and an index strongly associated with the cardiometabolic risk, was calculated as previously described [9].”
MethodVisceral adiposity index (VAI), a powerful predictor of incident hypertension in prehypertensives
Zhang, Z., Shi, D., Zhang, Q., Wang, S., Liu, K., Meng, Q., & Chen, X. (2018) · Internal and Emergency Medicine · doi:10.1007/s11739-018-1836-8 · Cited by 54
Metabolic Score for Visceral Fat: a novel predictor for the risk of type 2 diabetes mellitus
Feng, Y., Yang, X., Yang, L., Wu, Y., Han, M., Qie, R., Huang, S., Wu, X., Zhang, Y., Zhang, J.-L., et al. (2021) · British Journal Of Nutrition · doi:10.1017/s0007114521004116 · Cited by 54
Xiao, H., Xiong, C., Shao, X., Gao, P., Chen, H., Ning, J., Chen, Y., Zou, Z., Hong, G., Li, X., et al. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s231656 · Cited by 53
Zhang, C., Zhang, B., Zhang, X., Wang, M., Sun, X., & Sun, G. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.023540 · Cited by 53
Novel anthropometric indices for predicting type 2 diabetes mellitus
Sadeghi, E., Khodadadiyan, A., Hosseini, S. A., Hosseini, S. M., Aminorroaya, A., Amini, M., & Javadi, S. (2024) · BMC Public Health · doi:10.1186/s12889-024-18541-7 · Cited by 53
Androulakis, I. I., Kandaraki, E., Christakou, C., Karachalios, A., Marinakis, E., Paterakis, T., & Diamanti‐Kandarakis, E. (2014) · Clinical Endocrinology · doi:10.1111/cen.12447 · Cited by 41
Bi, H., Zhang, Y., Qin, P., Wang, C., Peng, X., Chen, H., Zhao, D., Xu, S., Wang, L., Zhao, P., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.022633 · Cited by 53
de Oliveira, C. M., Ulbrich, A. Z., Neves, F. S., Dias, F. A. L., Horimoto, A. R. V. R., Krieger, J. E., Alvim, R. D. O., & Pereira, A. C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185225 · Cited by 52
Izadi, A., Shirazi, S., Taghizadeh, S., & Gargari, B. P. (2019) · Archives of Medical Research · doi:10.1016/j.arcmed.2019.04.004 · Cited by 52
Cai, J., Lin, C., Lai, S., Liu, Y., Liang, M., Qin, Y., Liang, X., Tan, A., Gao, Y., Lu, Z., et al. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01568-9 · Cited by 52
Ramezani Tehrani, F., Minooee, S., & Azizi, F. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0094 · Cited by 51
“The VAI was calculated, as described by Amato et al. (2010) (17), using the following sex-specific equation: Female VAIZ WC 36:58C ð1:89!”
MethodZou, H., Ma, X., Zhang, F., & Xie, Y. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01902-3 · Cited by 51
Li, B., Wang, J., Zhou, X. J., Liu, Y., Wang, W., Gao, Z., Tang, X., Yan, L., Wan, Q., Luo, Z., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.921997 · Cited by 51
Fogacci, F., Giovannini, M., Micoli, V. D., Grandi, E., Borghi, C., & Cicero, A. F. G. (2024) · Nutrients · doi:10.3390/nu16152454 · Cited by 50
“The VAI normality cut-offs are 2.52 for individuals under 30 years, 2.23 for those aged between 30 and 42 years, 1.92 between 42 and 52 years, 1.93 between 52 and 66 years, and 2.00 for individuals over 66 years [19].”
BackgroundInfluentialSignificantly Increased Visceral Adiposity Index in Prehypertension
Ding, Y., Gu, D., Zhang, Y., Han, W., Liu, H., & Qu, Q. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123414 · Cited by 50
“VAI, a sex-specific index based on WC, BMI, TG and HDLC, was calculated as follows [5]:”
BackgroundMethodGoldani, H., Adami, F. S., Antunes, M. T., da Rosa, L. H. T., Fassina, P., Grave, M. T. Q., & Bosco, S. M. D. (2015) · PubMed · doi:10.3305/nh.2015.32.4.9589 · Cited by 50
The ZJU index is a powerful index for identifying NAFLD in the general Chinese population
Li, L., You, W., & Ren, W. (2017) · Acta Diabetologica · doi:10.1007/s00592-017-1024-8 · Cited by 50
Wang, S.-L., Ma, L., Chen, X., Zhou, D., Li, B., Huang, D., Yu, Z., Shen, X., & Zhuang, C. (2017) · European Journal of Clinical Nutrition · doi:10.1038/s41430-017-0032-7 · Cited by 50
“Compared with BMI, visceral fat is a more accurate parameter to reflect the dysfunctional adipose tissue, and it is considered to be associated with various obesity-related comorbidities [6, 7].”
BackgroundBarazzoni, R., Cappellari, G. G., Semolic, A., Ius, M., Zanetti, M., Gabrielli, A., Vinci, P., Guarnieri, G., & Simon, G. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2018.04.014 · Cited by 50
Tsou, M.-T., Chang, Y., Hsu, C.-P., Kuo, Y., Yun, C., Huang, W.-H., Hu, K., Liu, C., Chen, Y., Sung, K., et al. (2021) · Nutrition & Metabolism · doi:10.1186/s12986-021-00608-6 · Cited by 50
Visceral adiposity index is positively associated with blood pressure: A systematic review
Leite, N. N., Cota, B. C., Gotine, A. R. M., Rocha, D. M. U. P., Pereira, P. F., & Hermsdorff, H. H. M. (2021) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2021.10.001 · Cited by 50
Zhang, M., Li, Z., Li, P., Zhu, Y., Chang, H., Wang, X., Liu, W., Zhang, Y., & Huang, G. (2016) · Annals of Nutrition and Metabolism · doi:10.1159/000450657 · Cited by 49
Qin, Z., Jiang, L., Sun, J., Geng, J., Chen, S., Yang, Q., Su, B., & Liao, R. (2022) · Clinics · doi:10.1016/j.clinsp.2022.100114 · Cited by 49
Liu, C., Liu, X., Ma, X., Cheng, Y., Sun, Y., Zhang, D., Zhao, Q., & Zhou, Y. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00915-9 · Cited by 48
Zhu, Y., Zou, H., Guo, Y., Luo, P., Meng, X., Li, D., Xiang, Y., Mao, B., Pan, L., Kan, R., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110842 · Cited by 48
Elisha, B., Messier, V., Karelis, A. D., Coderre, L., Bernard, S., Prud’homme, D., & RABASA-LHORET, R. P. R. (2013) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2012-0307 · Cited by 48
“However, our findings are similar to a previous report (Amato et al. 2010).”
MethodResultInfluentialKoloverou, E., Panagiotakos, D. B., Kyrou, I., Stefanadis, C., Chrysohoou, C. A., Georgousopoulou, E. N., Skoumas, I., Tousoulis, D. M., Pitsavos, C. E., & the ATTICA Study group (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3161 · Cited by 48
“Compared with WC, as well as WHR and WHtR, which better reflect abdominal fat accumulation (both subcutaneous and visceral), VAI appears to reflect more accurately the accumulation and dysfunction of visceral adipose tissue.(1) This may be important for identifying the related cardiometabolic risk since, compared with…”
BackgroundInfluentialMa, Z., Xu, C., Kang, X., Zhang, S., Li, H., Tao, L., Zheng, D., Guo, X., & Yang, X. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02296-x · Cited by 48
Chiu, T.-H., Huang, Y., Chiu, H., Wu, P.-Y., Chiou, H.-Y. C., Huang, J., & Chen, S. (2020) · Diagnostics · doi:10.3390/diagnostics10121081 · Cited by 48
“and was found to be linked to CV risk [29].”
BackgroundPremature Ejaculation and Endocrine Disorders: A Literature Review
Coşkuner, E. R., & Özkan, B. (2021) · The World Journal of Men s Health · doi:10.5534/wjmh.200184 · Cited by 48
Predictors of non-alcoholic fatty liver disease in children
Li, M., Shu, W., Zunong, J., Amaerjiang, N., Xiao, H., Li, D., Vermund, S. H., & Hu, Y. (2021) · Pediatric Research · doi:10.1038/s41390-021-01754-6 · Cited by 48
Rysz, J. (2014) · Medical Science Monitor · doi:10.12659/msm.890845 · Cited by 48
Ji, B., Qu, H., Wang, H., Wei, H., & Deng, H. (2016) · Angiology · doi:10.1177/0003319716682120 · Cited by 48
Su, W., Chen, I.-H., Gau, Y., Wu, P.-Y., Huang, J., Tsai, Y., Chen, S., Chang, J., Hwang, S., & Chen, H. (2022) · Biomedicines · doi:10.3390/biomedicines10071744 · Cited by 47
Otsubo, N., Fukuda, T., Cho, G., Ishibashi, F., Yamada, T., & Monzen, K. (2022) · Internal Medicine · doi:10.2169/internalmedicine.1097-22 · Cited by 47
Pan, K., Wu, X., Xu, M., Feng, J., Xu, H., Gan, Y., Wang, C., Deng, Z., Liu, X., Fu, W., et al. (2021) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-021-01238-w · Cited by 47
Giordano, C. S. D. S., Ciresi, A., Amato, M. C., Pivonello, R., Auriemma, R. S., Grasso, L. F. S., Galluzzo, A., & Colao, A. A. L. (2011) · Pituitary · doi:10.1007/s11102-011-0365-5 · Cited by 47
Self-citationEndukuru, C. K., Gaur, G. S., Yerrabelli, D., Sahoo, J., & Vairappan, B. (2021) · Diabetology International · doi:10.1007/s13340-021-00522-5 · Cited by 46
Torun, C., Ankaralı, H. Ç., Caştur, L., Uzunlulu, M., Erbakan, A. N., Akbaş, M. M., Gündüz, N., Doğan, M. B., & Oğuz, A. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s421623 · Cited by 46
Amato, M. C., Guarnotta, V., Forti, D., Donatelli, M., Dolcimascolo, S., & Giordano, C. (2013) · Human Reproduction · doi:10.1093/humrep/det105 · Cited by 38
“…fat distribution and function, in addition to indirectly expressing altered production, release and/or function of adipocytokines and inflammatory factors, involved in the genesis of PCOS (Gambineri et al., 2002), also expresses a condition of cardiometabolic risk (Amato et al., 2010, 2011a,b).”
BackgroundMethodSelf-citationArancio, W., Amato, M. C., Magliozzo, M., Pizzolanti, G., Vesco, R., & Giordano, C. S. D. S. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1428299 · Cited by 46
Self-citationFerreira, F. G., Juvanhol, L. L., da Silva, D. C. G., & Longo, G. Z. (2018) · Public Health Nutrition · doi:10.1017/s136898001800335x · Cited by 46
“It was validated as a simple replacement marker of visceral adiposity and adipose dysfunction obtained by MRI((16)).”
BackgroundInfluentialLi, R. Q., Li, Q., Cui, M., Ying, Z., Li, L., Zhong, T., Huo, Y., & Xie, P. (2017) · Scientific Reports · doi:10.1038/s41598-017-07811-7 · Cited by 46
Vassilatou, E., Lafoyianni, S., Vassiliadi, D. A., Ioannidis, D., Paschou, S. Α., Mizamtsidi, M., Panagou, M., & Vryonidou, A. (2018) · Maturitas · doi:10.1016/j.maturitas.2018.06.013 · Cited by 46
Cen, C., Wang, W., Yu, S., Tang, X., Liu, J., Liu, Y., Zhou, L., Yu, J., & Zheng, S. (2020) · Hepatology International · doi:10.1007/s12072-020-10065-7 · Cited by 45
Nayak, V. K. R., Nayak, K. R., Vidyasagar, S., & Rekha, P. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.06.045 · Cited by 45
Advanced glycation end products and diabetes and other metabolic indicators
Jiang, T., Zhang, Y., Dai, F., Liu, C., Hu, H., & Zhang, Q. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00873-2 · Cited by 45
The degree of urinary hypercortisolism is not correlated with the severity of cushing’s syndrome
Guarnotta, V., Amato, M. C., Pivonello, R., Arnaldi, G., Ciresi, A., Trementino, L., Citarrella, R., Iacuaniello, D., Michetti, G., Simeoli, C., et al. (2016) · Endocrine · doi:10.1007/s12020-016-0914-9 · Cited by 45
Self-citationDereziński, T., Zozulińska‐Ziółkiewicz, D., Uruska, A. A., & Dąbrowski, M. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3052 · Cited by 45
Zuo, Y.-Q., Gao, Z.-H., Yin, Y.-L., Yang, X., & Feng, P. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s340595 · Cited by 44
van Son, K. C., Nijenhuis-Noort, L. C. T., Boone, S. C., Mook-Kanamori, D. O., Holleboom, A. G., Roos, P. R., Lamb, H. J., Alblas, G., Coenraad, M. J., Rosendaal, F. R., et al. (2024) · Medicine · doi:10.1097/md.0000000000034934 · Cited by 44
Li, Y., & Zeng, L. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1301543 · Cited by 44
“The VAI focuses more on the extent of visceral fat accumulation (22), as compared to the LAP with a higher overlap of calculated variables.”
Çatak, M., Konuk, Ş. G., & Hepşen, S. (2025) · Journal of Diabetes Investigation · doi:10.1111/jdi.70086 · Cited by 44
Comparison of Different Obesity Indices for Predicting Incident Hypertension
Janghorbani, M., Aminorroaya, A., & Amini, M. (2017) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-017-0186-3 · Cited by 44
“[11]), hypertriglyceridemic-waist (HTGW) phenotype (a combination of abdominal obesity and elevated fasting TG [12]) and lipid accumulation product (a combination of WC and TG [13, 14]) has been established to distinguish visceral fat from subcutaneous fat.”
BackgroundKavarić, N., Klisic, A. N., & Ninić, A. (2017) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.22283 · Cited by 44
Sun, K., Lin, D., Feng, Q., Feng, L., Qi, Y., Feng, W., Yang, C. H., Yan, L., Ren, M., & Liu, D. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0450-x · Cited by 44
The ZJU index is a powerful surrogate marker for NAFLD in severely obese North American women
Fu, C., Ali, H., Rachakonda, V. P., Oczypok, E. A., DeLany, J. P., & Kershaw, E. E. (2019) · PLoS ONE · doi:10.1371/journal.pone.0224942 · Cited by 44
“Therefore, noninvasive clinical scoring systems have been developed for identification of NAFLD, including Steatotest [11], Fatty liver index (FLI) [12], lipid accumulation production index (LAPI) [13], hepatic steatosis index (HSI) [14], and visceral adiposity index (VAI) [15].”
BackgroundWang, S., Huang, Y., Xu, H., Zhu, Q., Lu, H. K., Zhang, M., Hao, S., Fang, C., Zhang, D., Wu, X., et al. (2016) · European Journal of Nutrition · doi:10.1007/s00394-016-1241-x · Cited by 44
“White adipose tissue stores fat; thus, to examine the role that OTPs play in fat storage in white adipose tissue, the weights of visceral fat tissue were determined to calculate the adipose index [26].”
BackgroundWang, Y., He, S., He, J., Wang, S., Liu, K., & Chen, X. (2014) · Herz · doi:10.1007/s00059-014-4175-1 · Cited by 44
Bagyura, Z., Kiss, L. Z., Lux, Á., Csobay-Novák, C., Jermendy, Á. L., Polgár, L., Tabák, Á. G., Soós, P., Szelid, Z., Merkely, B. P., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087397 · Cited by 43
“It is calculated from body mass index and waist circumference, as well as triglyceride (TG) and high-density lipoprotein cholesterol (HDL-C) levels [4].”
BackgroundLi, Y., Gui, J., Zhang, X., Wang, Y., Mei, Y., Yang, X., Liu, H., Guo, L., Li, J., Lei, Y., et al. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03232-9 · Cited by 43
The association between visceral adiposity index and risk of type 2 diabetes mellitus
Zhou, H., Li, T., Li, J., Zhuang, X., & Yang, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-67430-x · Cited by 43
Russo, G. T., Labate, A., Giandalia, A., Romeo, E. L., Villari, P., Alibrandi, A., Perdichizzi, G., & Cucinotta, D. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0163-9 · Cited by 43
“The Visceral Adiposity Index (VAI) was calculated as described [16], using the following sex-specific equations, where waist circumference was expressed in cm, BMI in kg/m(2), triglycerides and HDL-C levels in mmol/L:”
BackgroundMethodResultInfluentialEbrahimi, S., Gargari, B. P., Aliasghari, F., Asjodi, F., & Izadi, A. (2019) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831/a000442 · Cited by 43
Lischka, J., Schanzer, A., Hojreh, A., Ssalamah, A. B., Item, C. B., de Gier, C., Walleczek, N., Metz, T. F., Jakober, I., Greber‐Platzer, S., et al. (2020) · Pediatric Obesity · doi:10.1111/ijpo.12739 · Cited by 43
Metabolism Score for Visceral Fat (METS-VF): A New Predictive Surrogate for CKD Risk
Feng, L., Chen, T., Wang, X., Xiong, C., Chen, J., Wu, S., Ning, J., & Zou, H. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s370222 · Cited by 43
Chen, J., Mao, X., Deng, M., & Luo, G. (2022) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002497 · Cited by 43
Visceral adiposity index score indicated the severity of coronary heart disease in Chinese adults
Han, L., Fu, K.-L., Zhao, J., Wang, Z., Tang, M., Wang, J., Wang, H., Zhang, Y., Zhang, W., & Zhong, M. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-143 · Cited by 43
“In our study, we defined VAD through the cut-off points derived from a Caucasian Sicilian population that Amato et al. study and found that VAD aggravated the severity of CHD in Chinese adults, suggesting that the cut-off points of VAI could be applied to CHD of Chinese in some extent.”
BackgroundMethodInfluentialWitarto, B. S., Witarto, A. P., Visuddho, V., Wungu, C. D. K., Maimunah, U., Rejeki, P. S., & Oceandy, D. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02190-1 · Cited by 42
Metabolic diseases in the East Asian populations
Sun, Z., & Zheng, Y. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01058-8 · Cited by 43
Erçin, C. N., Doğru, T., Genç, H., Çelebi, G., Aslan, F., Gürel, H., Kara, M., Sertoğlu, E., Tapan, S., Bağcı, S., et al. (2015) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0018 · Cited by 42
Stȩpień, M., Stępień, A., Banach, M., Wlazeł, R. N., Paradowski, M. T., Rizzo, M., Toth, P. P., & Rysz, J. (2013) · Angiology · doi:10.1177/0003319713485807 · Cited by 42
Balducci, S., Cardelli, P., Pugliese, L., D’Errico, V., Haxhi, J., Alessi, E., Iacobini, C., Menini, S., Bollanti, L., Conti, F., et al. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.05.033 · Cited by 42
Ma, C., Lu, N., Wang, R., Liu, X., Lü, Q., & Yin, F. (2017) · Scientific Reports · doi:10.1038/s41598-017-10446-3 · Cited by 42
Li, B., Lai, X., Yan, C., Jia, X., & Li, Y. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111019 · Cited by 42
Alkhalaqi, A., Al-Naimi, F., Qassmi, R., Shi, Z., Ganji, V., Salih, R. O. M., & Bawadi, H. A. (2020) · Medicine · doi:10.1097/md.0000000000021327 · Cited by 42
Associations of Heavy Metals with Metabolic Syndrome and Anthropometric Indices
Wen, W., Wang, C., Wu, D., Chen, S., Hung, C., & Kuo, C. (2020) · Nutrients · doi:10.3390/nu12092666 · Cited by 42
“VAI score was calculated as described previously [36] using the following sex-specific equations (with TG levels in mmol/L and HDL-cholesterol levels in mmol/L):”
MethodDing, S., Qi, W., Xu, Q., Zhao, T., Li, X., Yin, J., Zhang, R., Huo, C., Zhou, L., & Ye, L. (2021) · Environmental Pollution · doi:10.1016/j.envpol.2021.117570 · Cited by 42
Wang, L., & Zhong, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.975209 · Cited by 42
Behnoush, A. H., Bahiraie, P., Varniab, Z. S., Foroutani, L., & Khalaji, A. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01859-3 · Cited by 42
Chen, G., Qi, J.-C., Wang, B., Lin, X., Zhang, X., Zhao, J., Chen, X. F., Lin, T., Chen, D., & Lin, Q.-C. (2016) · BMC Pulmonary Medicine · doi:10.1186/s12890-016-0198-0 · Cited by 42
Xie, X., Li, Q., Zhang, L., & Ren, W. (2017) · Endocrine Practice · doi:10.4158/ep-2017-0007 · Cited by 42
Muzsik, A., Jeleń, H. H., & Chmurzyńska, A. (2020) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2020.102155 · Cited by 41
Zhang, H., Qi, Z., Dong, F., Gao, X., Zeng, F., Yao, J., Gan, Y., Zou, S., Gu, J., Fu, H., et al. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01843-x · Cited by 41
Techatraisak, K., Wongmeerit, K., Dangrat, C., Wongwananuruk, T., & Indhavivadhana, S. (2016) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1112785 · Cited by 37
Adipose Tissue Dysfunction: Clinical Relevance and Diagnostic Possibilities
Schrover, I. M., Spiering, W., Leiner, T., & Visseren, F. L. J. (2016) · Hormone and Metabolic Research · doi:10.1055/s-0042-103243 · Cited by 41
Indicators of Adiposity Predictors of Metabolic Syndrome in the Elderly
de Oliveira, C. C., Roriz, A. K. C., Ramos, L. B., & Neto, M. G. (2017) · Annals of Nutrition and Metabolism · doi:10.1159/000455333 · Cited by 41
Mazidi, M., Kengne, A. P., George, E. S., & Siervo, M. (2019) · British Journal Of Nutrition · doi:10.1017/s0007114519002149 · Cited by 41
“The visceral adiposity index (VAI) is another indicator of adipose tissue distribution which has been used in the stratification of adult obesity phenotypes (14) and to improve the prediction of cardio-metabolic risk (15) .”
Choi, H. S., Cho, Y. H., Lee, S. Y., Park, E. J., Kim, Y. J., Lee, J. G., Yi, Y. H., Tak, Y. J., Hwang, H. R., & Lee, S. H. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s211542 · Cited by 41
Nishigori, T., Obama, K., & Sakai, Y. (2020) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2019.10.13 · Cited by 41
“The association between visceral fat and metabolic syndrome and other serious diseases is well known (65-68).”
BackgroundZou, J., Wang, Y., Xu, H., Xia, Y., Qian, Y., Zou, J., Guan, J., Chen, B., Yi, H., & Yin, S. (2019) · Sleep And Breathing · doi:10.1007/s11325-019-01980-7 · Cited by 41
Qorbani, M., Khashayar, P., Rastad, H., Ejtahed, H., Shahrestanaki, E., Seif, E., Daniali, S. S., Goudarzi, M., Motlagh, M. E., Khodaparast, Z., et al. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00617-0 · Cited by 41
Matsubayashi, Y., Fujihara, K., Yamada, M. H., Mitsuma, Y., Sato, T., Yaguchi, Y., OSAWA, T., Yamamoto, M., Kitazawa, M., Yamada, T., et al. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01518-4 · Cited by 41
Metadata
- Authors
- Amato, M. C., Giordano, C., Galia, M., Criscimanna, A., Vitabile, S., Midiri, M., Galluzzo, A., & for the AlkaMeSy Study Group
- Affiliations
- University of Palermo (IT)
- Corresponding author
- Galluzzo, Aldo
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-01-12
- Volume
- 33
- Issue
- 4
- Pages
- 920-922
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2845052
- OpenAlex
- W2125944762
- Cited by
- 1,751
- References
- 14
- Citations by year
- 2026: 157 · 2025: 293 · 2024: 211 · 2023: 184 · 2022: 198 · 2021: 157 · 2020: 121 · 2019: 106 · 2018: 66 · 2017: 52 · 2016: 56 · 2015: 43 · 2014: 46 · 2013: 28 · 2012: 17
- FWCI
- 14.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- visceral adiposity index, visceral fat, waist circumference, body mass index, triglycerides, HDL cholesterol, metabolic syndrome, cardiovascular risk, cerebrovascular risk, insulin sensitivity, cardiometabolic risk
- MeSH terms
- Adult, Aged, Aged, 80 and over, Cardiovascular Diseases, Female, Humans, Cholesterol, HDL, Male, Middle Aged, Risk Factors, Triglycerides, Body Mass Index, Logistic Models, Intra-Abdominal Fat, Waist Circumference, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.